LMNA and familial dilated cardiomyopathy: Various transgenic mouse models have been adopted to further study the mechanisms and potential treatment of laminopathy-related DCM, such as LMNA p.E82K, p.R225X, and p.Q353R transgenic mice [27,37,39,43].